Publications by authors named "T G Cotter"
Introduction: Alcohol-associated liver disease (ALD) disproportionately impacts men, racial and ethnic minorities, and individuals of low socioeconomic status; however, it's unclear how recent increases in ALD burden have impacted these disparities. We aimed to describe trends in racial, ethnic and socioeconomic disparities in alcohol-associated hospital encounters.
Methods: We conducted a retrospective cohort study of adult hospital encounters with alcohol-associated diagnoses from three health systems between January 2016 and December 2021.
Advances in the management of alcohol-associated liver disease.
Gastroenterol Rep (Oxf)
November 2024
Alcohol-associated liver disease (ALD) is a significant global health challenge, encompassing a spectrum from steatotic liver disease to cirrhosis and alcohol-associated hepatitis, and contributed to 25% of global cirrhosis deaths in 2019. The identification of both modifiable (e.g.
View Article and Find Full Text PDFArticle Synopsis
- - The 2023 nomenclature for steatotic liver disease (SLD) encompasses metabolic dysfunction-associated SLD (MASLD), alcohol-associated liver disease (ALD), and a mix of both (MetALD), prompting a study on racial and ethnic disparities in SLD prevalence among US adults.
- - Data from the 2017-2018 National Health and Nutrition Examination Survey (NHANES) revealed that 42.4% of participants had MASLD, while the rates for MetALD and ALD were significantly lower (1.7% and 0.6%, respectively), with a higher prevalence observed in Hispanic individuals.
- - Factors such as male gender, age, higher BMI, and various
Background: Outcomes in alcohol-associated liver disease (ALD) are influenced by several race and ethnic factors, yet its natural history across the continuum of patients in different stages of the disease is unknown.
Methods: We conducted a retrospective cohort study of U.S.